Clinical Trial Update: QUILT-3.009: Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) [Phase 2]

View source ↗

Summary

Phase 2 QUILT-3.009 trial in Stage IIIB and Stage IV Merkel cell carcinoma sponsored by ImmunityBio has been terminated; results are posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Merkel Cell Carcinoma

Snippet

Sponsor: ImmunityBio, Inc. | Conditions: Stage IIIB Merkel Cell Carcinoma, Stage IV Merkel Cell Carcinoma | Phase 2 | Status: TERMINATED | Results posted: 2024-05-02